Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001567619-21-007700

President and CEO sold 1,750 shares at $29.93 ($52,378)

From the SEC's structured data for this filing

Trades in this filing

Watanabe Todd Franklin · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-04-05 Sale : show line 1 in the form −1,750 $29.93 $52,378 595,416 D
Open-market sales · 1,750 sh · avg $29.93 · $52,378
Loading xslF345X03/doc1.xml…